Drugs bound to albumin selectively target cancer cells with upregulated macropinocytosis, an endocytic nutrient‐scavenging process driven by constitutive hyper‐activation of the EGFR/RAS/PIK3CA signaling and Syndecan1 pathways [7, 8, 9, 10, 11, 12]. Here, EGFR is linked to cancer.